Suppr超能文献

激酶结构域插入决定了CLK激酶在SR蛋白磷酸化中的不同作用。

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.

作者信息

Bullock Alex N, Das Sanjan, Debreczeni Judit E, Rellos Peter, Fedorov Oleg, Niesen Frank H, Guo Kunde, Papagrigoriou Evangelos, Amos Ann L, Cho Suhyung, Turk Benjamin E, Ghosh Gourisankar, Knapp Stefan

机构信息

Structural Genomics Consortium, University of Oxford, Old Road Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.

出版信息

Structure. 2009 Mar 11;17(3):352-62. doi: 10.1016/j.str.2008.12.023.

Abstract

Splicing requires reversible phosphorylation of serine/arginine-rich (SR) proteins, which direct splice site selection in eukaryotic mRNA. These phosphorylation events are dependent on SR protein (SRPK) and cdc2-like kinase (CLK) families. SRPK1 phosphorylation of splicing factors is restricted by a specific docking interaction whereas CLK activity is less constrained. To understand functional differences between splicing factor targeting kinases, we determined crystal structures of CLK1 and CLK3. Intriguingly, in CLKs the SRPK1 docking site is blocked by insertion of a previously unseen helix alphaH. In addition, substrate docking grooves present in related mitogen activating protein kinases (MAPKs) are inaccessible due to a CLK specific beta7/8-hairpin insert. Thus, the unconstrained substrate interaction together with the determined active-site mediated substrate specificity allows CLKs to complete the functionally important hyperphosphorylation of splicing factors like ASF/SF2. In addition, despite high sequence conservation, we identified inhibitors with surprising isoform specificity for CLK1 over CLK3.

摘要

剪接需要富含丝氨酸/精氨酸(SR)的蛋白质进行可逆磷酸化,这些蛋白质指导真核生物mRNA中的剪接位点选择。这些磷酸化事件依赖于SR蛋白(SRPK)和类cdc2激酶(CLK)家族。剪接因子的SRPK1磷酸化受到特定对接相互作用的限制,而CLK活性的限制则较少。为了了解靶向激酶的剪接因子之间的功能差异,我们确定了CLK1和CLK3的晶体结构。有趣的是,在CLKs中,SRPK1对接位点被一个先前未见过的αH螺旋插入所阻断。此外,由于CLK特异性的β7/8发夹插入,相关的丝裂原活化蛋白激酶(MAPKs)中存在的底物对接凹槽无法进入。因此,不受限制的底物相互作用以及确定的活性位点介导的底物特异性使CLKs能够完成对剪接因子如ASF/SF2的功能上重要的过度磷酸化。此外,尽管序列保守性很高,但我们还是鉴定出了对CLK1比对CLK3具有惊人异构体特异性的抑制剂。

相似文献

1
Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
Structure. 2009 Mar 11;17(3):352-62. doi: 10.1016/j.str.2008.12.023.
4
N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation.
Biochem J. 2014 Aug 15;462(1):143-52. doi: 10.1042/BJ20140494.
5
Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases.
J Mol Biol. 2013 Aug 23;425(16):2894-909. doi: 10.1016/j.jmb.2013.05.013. Epub 2013 May 23.
7
Splicing kinase SRPK1 conforms to the landscape of its SR protein substrate.
Biochemistry. 2013 Oct 29;52(43):7595-605. doi: 10.1021/bi4010864. Epub 2013 Oct 15.
8
Mass spectrometric and kinetic analysis of ASF/SF2 phosphorylation by SRPK1 and Clk/Sty.
J Biol Chem. 2005 Dec 16;280(50):41761-8. doi: 10.1074/jbc.M504156200. Epub 2005 Oct 13.

引用本文的文献

1
Mesoscale proximity labeling to study macro changes to chromatin occupancy.
bioRxiv. 2025 Mar 15:2025.03.13.643041. doi: 10.1101/2025.03.13.643041.
2
Advances in Protein Kinase Regulation of Stress Responses in Fruits and Vegetables.
Int J Mol Sci. 2025 Jan 17;26(2):768. doi: 10.3390/ijms26020768.
3
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity.
Future Med Chem. 2024;16(12):1239-1254. doi: 10.1080/17568919.2024.2342708. Epub 2024 May 22.
4
CDC-like kinase 3 deficiency aggravates hypoxia-induced cardiomyocyte apoptosis through AKT signaling pathway.
In Vitro Cell Dev Biol Anim. 2024 Apr;60(4):333-342. doi: 10.1007/s11626-024-00886-3. Epub 2024 Mar 4.
6
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4.
Curr Res Chem Biol. 2023;3. doi: 10.1016/j.crchbi.2023.100045. Epub 2023 Sep 22.
7
Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders.
FEBS Lett. 2023 Oct;597(19):2375-2415. doi: 10.1002/1873-3468.14723. Epub 2023 Sep 4.
8
CMGC Kinases in Health and Cancer.
Cancers (Basel). 2023 Jul 28;15(15):3838. doi: 10.3390/cancers15153838.
10
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases.
Signal Transduct Target Ther. 2023 Apr 7;8(1):148. doi: 10.1038/s41392-023-01409-4.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Linear motif atlas for phosphorylation-dependent signaling.
Sci Signal. 2008 Sep 2;1(35):ra2. doi: 10.1126/scisignal.1159433.
4
Ordered multi-site phosphorylation of the splicing factor ASF/SF2 by SRPK1.
J Mol Biol. 2008 Feb 8;376(1):55-68. doi: 10.1016/j.jmb.2007.08.029. Epub 2007 Aug 21.
5
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8. doi: 10.1073/pnas.0708800104. Epub 2007 Dec 11.
8
The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
Nat Struct Mol Biol. 2007 Mar;14(3):185-93. doi: 10.1038/nsmb1209. Epub 2007 Feb 18.
9
SR protein kinase 1 is resilient to inactivation.
Structure. 2007 Jan;15(1):123-33. doi: 10.1016/j.str.2006.11.011.
10
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination.
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15835-40. doi: 10.1073/pnas.0605224103. Epub 2006 Oct 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验